Bellerophon Therapeutics Inc
F:6L7A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bellerophon Therapeutics Inc
F:6L7A
|
US |
|
TDH Holdings Inc
NASDAQ:PETZ
|
CN |
|
Noevir Holdings Co Ltd
TSE:4928
|
JP |
|
McCormick & Company Inc
NYSE:MKC
|
US |
|
N
|
National Vision Holdings Inc
F:7NV
|
US |
|
Chicago Atlantic Real Estate Finance Inc
NASDAQ:REFI
|
US |
|
Bharat Seats Ltd
BSE:523229
|
IN |
|
Nepi Rockcastle NV
AEX:NRP
|
NL |
|
M
|
MFE-MEDIAFOREUROPE NV
F:T0J0
|
IT |
|
W
|
Westport Fuel Systems Inc
NASDAQ:WPRT
|
CA |
|
I
|
Infratil Ltd
ASX:IFT
|
NZ |
|
Vodafone Group PLC
LSE:VOD
|
UK |
|
E.ON SE
LSE:0MPP
|
DE |
|
G
|
Goldwind Science & Technology Co Ltd
XMUN:CXGH
|
CN |
|
Crown Holdings Inc
NYSE:CCK
|
US |
|
Joint Corp
NASDAQ:JYNT
|
US |
|
J
|
JK Paper Ltd
BSE:532162
|
IN |
|
Okta Inc
NASDAQ:OKTA
|
US |
Bankruptcy Probability
Bellerophon Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Bellerophon Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
B
|
Bellerophon Therapeutics Inc
F:6L7A
|
3.7m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
154B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
147.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
117.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
103.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
69.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
50.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
39.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
41.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
29.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Bellerophon Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Bellerophon Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
